Figure 1. hPDL1 expression in wild-type MC38 and MC38-hPDL1 cell lines.
Figure 2. Tumor growth curve of MC38-hPDL1 syngeneic model (n=3).
Figure 3. The expression of hPDL1 in humanized modified tumors by FACS.
Figure 4. Antitumor activity of Tencentriq and another anti-PDL1 antibody (n=8).
Please fill in the order form and we will contact you within 2 working days.
